Search Results - "Pereira, Cláudia V"

Refine Results
  1. 1
  2. 2

    Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia by Lumini-Oliveira, José, Magalhães, José, Pereira, Cláudia V, Moreira, Ana C, Oliveira, Paulo J, Ascensão, António

    Published in Mitochondrion (01-01-2011)
    “…The present study analyzed the effects of endurance training against cardiac mitochondrial dysfunction, particularly on the susceptibility to mitochondrial…”
    Get full text
    Journal Article
  3. 3

    Mechanisms of Berberine (Natural Yellow 18)–Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator by Pereira, Cláudia V., Machado, Nuno G., Oliveira, Paulo J.

    Published in Toxicological sciences (01-10-2008)
    “…Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo (5,6-a) quinolizinium] is an alkaloid present in plants of the Berberidaceae…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Rapeseed oil-rich diet alters hepatic mitochondrial membrane lipid composition and disrupts bioenergetics by Monteiro, João P., Pereira, Cláudia V., Silva, Ana M., Maciel, Elisabete, Baldeiras, Inês, Peixoto, Francisco, Domingues, Maria R., Jurado, Amália S., Oliveira, Paulo J.

    Published in Archives of toxicology (01-12-2013)
    “…Diet is directly related with physiological alterations occurring at a cell and subcellular level. However, the role of diet manipulation on mitochondrial…”
    Get full text
    Journal Article
  6. 6

    Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? by Pereira, Cláudia V, Moreira, Ana C, Pereira, Susana P, Machado, Nuno G, Carvalho, Filipa S, Sardão, Vilma A, Oliveira, Paulo J

    Published in Current drug safety (01-01-2009)
    “…Mitochondria are recognized as the producers of the majority of energy cells need for their normal activity. After the initial comprehension of how…”
    Get more information
    Journal Article
  7. 7

    Edelfosine and perifosine disrupt hepatic mitochondrial oxidative phosphorylation and induce the permeability transition by Burgeiro, Ana, Pereira, Cláudia V, Carvalho, Filipa S, Pereira, Gonçalo C, Mollinedo, Faustino, Oliveira, Paulo J

    Published in Mitochondrion (01-01-2013)
    “…Edelfosine and perifosine are alkylphospholipids that have been intensively studied as potential antitumor agents. Apoptotic cell death caused by these two…”
    Get full text
    Journal Article
  8. 8

    Long-term hyperglycaemia decreases gastrocnemius susceptibility to permeability transition by Lumini-Oliveira, José, Ascensão, António, Pereira, Cláudia V., Magalhães, Sérgio, Marques, Franklin, Oliveira, Paulo J., Magalhães, José

    Published in European journal of clinical investigation (01-04-2010)
    “…Eur J Clin Invest 2010; 40 (4): 319–329 Background  Hyperglycaemia‐resulting in mitochondrial bioenergetics’ complications is associated with skeletal muscle…”
    Get full text
    Journal Article
  9. 9

    MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation by Bacman, Sandra R., Kauppila, Johanna H. K., Pereira, Claudia V., Nissanka, Nadee, Miranda, Maria, Pinto, Milena, Williams, Sion L., Larsson, Nils-Göran, Stewart, James B., Moraes, Carlos T.

    Published in Nature medicine (01-11-2018)
    “…Mutations in the mitochondrial DNA (mtDNA) are responsible for several metabolic disorders, commonly involving muscle and the central nervous system 1 …”
    Get full text
    Journal Article
  10. 10

    Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo by Zekonyte, Ugne, Bacman, Sandra R., Smith, Jeff, Shoop, Wendy, Pereira, Claudia V., Tomberlin, Ginger, Stewart, James, Jantz, Derek, Moraes, Carlos T.

    Published in Nature communications (28-05-2021)
    “…Diseases caused by heteroplasmic mitochondrial DNA mutations have no effective treatment or cure. In recent years, DNA editing enzymes were tested as tools to…”
    Get full text
    Journal Article
  11. 11

    Endurance training improves gastrocnemius mitochondrial function despite increased susceptibility to permeability transition by Lumini-Oliveira, José, Magalhães, José, Pereira, Cláudia V, Aleixo, Inês, Oliveira, Paulo J, Ascensão, António

    Published in Mitochondrion (01-11-2009)
    “…The aim of the present work was to test the hypothesis that moderate endurance treadmill training ameliorates gastrocnemius mitochondrial bioenergetics and…”
    Get full text
    Journal Article
  12. 12

    mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels by Pereira, Claudia V, Bacman, Sandra R, Arguello, Tania, Zekonyte, Ugne, Williams, Sion L, Edgell, David R, Moraes, Carlos T

    Published in EMBO molecular medicine (01-09-2018)
    “…Pathogenic mitochondrial DNA (mtDNA) mutations often co‐exist with wild‐type molecules (mtDNA heteroplasmy). Phenotypes manifest when the percentage of mutant…”
    Get full text
    Journal Article
  13. 13

    Multiple distinct evolutionary mechanisms govern the dynamics of selfish mitochondrial genomes in Caenorhabditis elegans by Gitschlag, Bryan L., Pereira, Claudia V., Held, James P., McCandlish, David M., Patel, Maulik R.

    Published in Nature communications (19-09-2024)
    “…Cells possess multiple mitochondrial DNA (mtDNA) copies, which undergo semi-autonomous replication and stochastic inheritance. This enables mutant mtDNA…”
    Get full text
    Journal Article
  14. 14

    Myopathy reversion in mice after restauration of mitochondrial complex I by Pereira, Claudia V, Peralta, Susana, Arguello, Tania, Bacman, Sandra R, Diaz, Francisca, Moraes, Carlos T

    Published in EMBO molecular medicine (07-02-2020)
    “…Myopathies are common manifestations of mitochondrial diseases. To investigate whether gene replacement can be used as an effective strategy to treat or cure…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response by Held, James P, Feng, Gaomin, Saunders, Benjamin R, Pereira, Claudia V, Burkewitz, Kristopher, Patel, Maulik R

    Published in eLife (22-04-2022)
    “…The mitochondrial unfolded protein response (UPR ) has emerged as a predominant mechanism that preserves mitochondrial function. Consequently, multiple…”
    Get full text
    Journal Article
  17. 17

    Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific by Pereira, Gonçalo C, Pereira, Susana P, Pereira, Claudia V, Lumini, José A, Magalhães, José, Ascensão, António, Santos, Maria S, Moreno, António J, Oliveira, Paulo J

    Published in PloS one (22-06-2012)
    “…Although doxorubicin (DOX) is a very effective antineoplastic agent, its clinical use is limited by a dose-dependent, persistent and cumulative cardiotoxicity,…”
    Get full text
    Journal Article
  18. 18

    Cellular mechanisms of mtDNA heteroplasmy dynamics by Pereira, Claudia V, Gitschlag, Bryan L, Patel, Maulik R

    “…Heteroplasmy refers to the coexistence of more than one variant of the mitochondrial genome (mtDNA). Mutated or partially deleted mtDNAs can induce chronic…”
    Get more information
    Journal Article
  19. 19

    Current strategies towards therapeutic manipulation of mtDNA heteroplasmy by Pereira, Claudia V, Moraes, Carlos T

    Published in Frontiers in bioscience (01-01-2017)
    “…Mitochondrial disease is a multifactorial disorder involving both nuclear and mitochondrial genomes. Over the past 20 years, great progress was achieved in the…”
    Get full text
    Journal Article
  20. 20

    SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency by Rebelo, Adriana P, Saade, Dimah, Pereira, Claudia V, Farooq, Amjad, Huff, Tyler C, Abreu, Lisa, Moraes, Carlos T, Mnatsakanova, Diana, Mathews, Kathy, Yang, Hua, Schon, Eric A, Zuchner, Stephan, Shy, Michael E

    Published in Brain (London, England : 1878) (01-03-2018)
    “…Recessive mutations in the mitochondrial copper-binding protein SCO2 have been described in cases of fatal infant cardioencephalomyopathy with COX deficiency…”
    Get full text
    Journal Article